Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05695664

Postoperative Analgesic Effects of Ibuprofen Versus Ketorolac in Patients Undergoing in Orthopedic Surgery

Conditions: Intravenous Drug Usage, Ibuprofen, Ketorolac, Knee Arthroscopy, Postoperative Pain

Sex: All
Ages: 40 Years – 80 Years
Phase: EARLY_PHASE1
Enrollment: 100
Sponsor: Benazir Bhutto Hospital, Rawalpindi

Location: Pakistan

Summary

Objectives: To compare the postoperative analgesic effects of ibuprofen versus ketorolac in patients undergoing orthopedic surgery at Combined Military Hospital, Rawalpindi.Study design: Randomized controlled trial Setting: Department of Anasthesiology, Combined military Hospital, Rawalpindi Duration of study:6 months (01st August 2021 to 31st January 2022) Material and methods: After ethical approval, 100 patients in randomly divided two equal groups (A and B) were selected. In group A, 800 mg IV ibuprofen while in group B, 30 mg IV ketorolac was given within 30 min of skin closure after orthopedic surgery. The pain was assessed via visual analogue scale postoperatively. The SPSS version 25 was used for analysis of data. P value ≤ 0.05 was considered as significant.

Eligibility Criteria

Inclusion Criteria:Patients of either gender undergo orthopedic surgery were included in the study.ASA ≤ 2Age 40-80 years.Fracture Radius , Ulna, and wristExclusion Criteria:Patients with history of adverse response from ketorolac and ibuprofen was not taken into the study.Patients with history of epilepsy.Patients with history of cardiac conduction defects.Patients on antiarrhythmic drugs or analgesics.Patients with H/O stroke, renal impairment, chronic obstructive pulmonary disease, asthma, chronic liver disease, hypothyroidism and CCF were excluded.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05695664). StuddyBuddy aggregates publicly available trial information.